×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EWTX – edgewise therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EWTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/5
05:39 pm
ewtx
Edgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your Money [Yahoo! Finance]
Medium
Report
Edgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your Money [Yahoo! Finance]
4/3
11:34 am
ewtx
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its price target lowered by analysts at Royal Bank of Canada from $56.00 to $52.00. They now have an "outperform" rating on the stock.
Medium
Report
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its price target lowered by analysts at Royal Bank of Canada from $56.00 to $52.00. They now have an "outperform" rating on the stock.
4/2
06:21 pm
ewtx
Why Edgewise Therapeutics And Cytokinetics Stocks Just Diverged [Yahoo! Finance]
Medium
Report
Why Edgewise Therapeutics And Cytokinetics Stocks Just Diverged [Yahoo! Finance]
4/2
02:15 pm
ewtx
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $51.00 price target on the stock.
Low
Report
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $51.00 price target on the stock.
4/2
12:18 pm
ewtx
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $14.00 price target on the stock.
Medium
Report
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $14.00 price target on the stock.
4/2
12:18 pm
ewtx
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $14.00 price target on the stock.
Medium
Report
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) was downgraded by analysts at Scotiabank from a "sector outperform" rating to a "sector perform" rating. They now have a $14.00 price target on the stock.
4/2
06:22 am
ewtx
Edgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common Stock
High
Report
Edgewise Therapeutics Announces Pricing of $200 Million Underwritten Offering of Common Stock
4/2
06:16 am
ewtx
Edgewise Therapeutics Announces Positive Top-Line Results from Phase 2 CIRRUS-HCM Four-Week Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) [Yahoo! Finance]
High
Report
Edgewise Therapeutics Announces Positive Top-Line Results from Phase 2 CIRRUS-HCM Four-Week Trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
3/3/2025
08:00 am
ewtx
edgewise therapeutics, inc.
MISS
Report
-4.7%
edgewise therapeutics, inc.
3/3/2025
08:00 am
ewtx
edgewise therapeutics, inc.
MISS
Report
-2.2%
edgewise therapeutics, inc.
3/3/2025
08:00 am
ewtx
edgewise therapeutics, inc.
MISS
Report
-2.2%
edgewise therapeutics, inc.
3/3/2025
08:00 am
ewtx
edgewise therapeutics, inc.
MISS
Report
-2.2%
edgewise therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/4
07:42 pm
ewtx
Form 4 Edgewise Therapeutics, For: Apr 03 Filed by: Thompson Peter A.
Low
Report
Form 4 Edgewise Therapeutics, For: Apr 03 Filed by: Thompson Peter A.
4/4
07:33 pm
ewtx
Form 4 Edgewise Therapeutics, For: Apr 03 Filed by: OrbiMed Genesis GP LLC
Medium
Report
Form 4 Edgewise Therapeutics, For: Apr 03 Filed by: OrbiMed Genesis GP LLC
4/3
06:11 pm
ewtx
Form 4 Edgewise Therapeutics, For: Apr 01 Filed by: Fox Jonathan C
High
Report
Form 4 Edgewise Therapeutics, For: Apr 01 Filed by: Fox Jonathan C
4/2
05:18 pm
ewtx
Form 424B5 Edgewise Therapeutics,
Medium
Report
Form 424B5 Edgewise Therapeutics,
4/2
06:29 am
ewtx
Form 8-K Edgewise Therapeutics, For: Apr 02
High
Report
Form 8-K Edgewise Therapeutics, For: Apr 02
4/2
06:06 am
ewtx
Form 8-K Edgewise Therapeutics, For: Apr 02
High
Report
Form 8-K Edgewise Therapeutics, For: Apr 02
3/11
04:33 pm
ewtx
Form 4 Edgewise Therapeutics, For: Mar 07 Filed by: Russell Alan J
Medium
Report
Form 4 Edgewise Therapeutics, For: Mar 07 Filed by: Russell Alan J
3/11
04:32 pm
ewtx
Form 4 Edgewise Therapeutics, For: Mar 07 Filed by: KOCH KEVIN
Medium
Report
Form 4 Edgewise Therapeutics, For: Mar 07 Filed by: KOCH KEVIN
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: